Page 113 - EJMO-9-1

Eurasian Journal of Medicine and
Oncology
Genomics of breast cancer in Western Kazakhstan

Author contributions J Surg Oncol. 2020;122(2):134-143.

Conceptualization: Marzhan Aitmagambetova, Gaziza doi: 10.1002/jso.25956
Smagulova, Nurgul Ablakimova 4. Roberts E, Howell S, Evans DG. Polygenic risk scores and
Formal analysis: Anar Tulyayeva, Nurgul Kereyeva, Dinara breast cancer risk prediction. Breast. 2023;67:71-77.
Zholmukhamedova, Azamat Zharylgapov, Nazar doi: 10.1016/j.breast.2023.01.003
Seidalin
Investigation: Anar Tulyayeva, Nurgul Kereyeva, Dinara 5. Yoshida R. Hereditary breast and ovarian cancer (HBOC):
Review of its molecular characteristics, screening, treatment,
Zholmukhamedova, Azamat Zharylgapov, Nazar and prognosis. Breast Cancer. 2021;28(6):1167-1180.
Seidalin
Methodology: Saule Balmagambetova, Marzhan doi: 10.1007/s12282-020-01148-2
Aitmagambetova, Nurgul Ablakimova 6. Consortium BCA. Breast cancer risk genes-association
Writing – original draft: Marzhan Aitmagambetova, analysis in more than 113,000 women. N Engl J Med.
Nurgul Ablakimova 2021;384(5):428-439.
Writing – review & editing: Nazar Seidalin, Dmitriy doi: 10.1056/NEJMoa1913948
Babenko, Anar Tulyayeva, Arip Koishybaev, 7. Abu-Helalah M, Azab B, Mubaidin R, et al. BRCA1 and
Saule Balmagambetova, Nurgul Kereyeva, Dinara BRCA2 genes mutations among high risk breast cancer
Zholmukhamedova, Gaziza Smagulova, Azamat patients in Jordan. Sci Rep. 2020;10(1):17573.
Zharylgapov, Nauryzbay Imanbaev
doi: 10.1038/s41598-020-74250-2
Ethics approval and consent to participate 8. Gao Y, Samreen N, Heller SL. Non-BRCA early-onset breast
This research was approved by the Bioethics Committee of cancer in Young Women. Radiographics. 2022;42(1):5-22.
the West Kazakhstan Marat Ospanov Medical University doi: 10.1148/rg.210109
(Protocol No. 24 dated October 3, 2017). Written informed 9. Wood ME, McKinnon W, Garber J. Risk for breast cancer
consent was obtained from all participants involved in the and management of unaffected individuals with non-BRCA
study. hereditary breast cancer. Breast J. 2020;26(8):1528-1534.

Consent for publication doi: 10.1111/tbj.13969
10. French JD, Edwards SL. Genetic determinants of breast
Participants provided permission for the collection, cancer risk. Curr Opinion Endocr Metab Res. 2020;15:1-7.
analysis, and publication of their data, including any
images. Every effort was made to mask or conceal doi: 10.1016/j.coemr.2020.07.009
identifying information in the manuscript. 11. Kang D, Choi JY. Breast cancer-related low penetrance
genes. Adv Exp Med Biol. 2021;1187:419-434.
Availability of data
doi: 10.1007/978-981-32-9620-6_22
The data used in this study are available from the 12. Mulerova T, Ogarkov M. Interethnic associations of
corresponding author upon reasonable request. Interested increased heart rate as a factor of cardiovascular risk. Part 2:
readers may contact the authors for access to the datasets. Genetic markers. Eurasian Cardiol J. 2021;(1):88-93

References 13. Shu J, Hui X, Zheng X, et al. Correlation of FGFR2 rs2981582
polymorphisms with susceptibility to breast cancer: A case-
1. Bray F, Laversanne M, Sung H, et al. Global cancer statistics control study in a Chinese population. J Int Med Res.
2022: GLOBOCAN estimates of incidence and mortality 2019;47(10):4753-4763.
worldwide for 36 cancers in 185 countries. CA Cancer J Clin.
2024;74(3):229-263. doi: 10.1177/0300060519869058
14. Boyarskikh UA, Zarubina NA, Biltueva JA, et al. Association
doi: 10.3322/caac.21834
of FGFR2 gene polymorphisms with the risk of breast
2. Igissin N, Toguzbayeva A, Khamidullina Z, et al. cancer in population of West Siberia. Eur J Hum Genet.
Epidemiology of breast cancer mortality in Kazakhstan, 2009;17(12):1688-1691.
trends and geographic distribution. Asian Pacific Journal of
Cancer Prevention. 2023;24(10):3361. doi: 10.1038/ejhg.2009.98
15. Aminkeng F, Bhavsar AP, Visscher H, et al. A coding
doi: 10.31557/APJCP.2023.24.10.3361
variant in RARG confers susceptibility to anthracycline-
3. Ladd MK, Peshkin BN, Isaacs C, et al. Predictors of genetic induced cardiotoxicity in childhood cancer. Nat Genet.
testing uptake in newly diagnosed breast cancer patients. 2015;47(9):1079-1084.

Volume 9 Issue 1 (2025) 105 doi: 10.36922/ejmo.5385